Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore a comprehensive 59-minute lecture from Stanford University's Diabetes Wellness Group Monthly Webinar series where Clinical Pharmacist Michael Blyumin delves into the world of GLP-1 receptor agonists. Gain deep insights into FDA-approved medications like Exenatide, Liraglutide, and Semaglutide, understanding their dosing protocols, administration methods, and therapeutic benefits including blood sugar control, weight management, and cardiovascular health improvements. Master the fundamentals of diabetes pathophysiology, learn how GLP-1s regulate blood sugar levels, and understand the intricate mechanisms of GLP-1 receptor agonists. Examine practical considerations for diabetes management, potential risks, and the implications of discontinuing these medications. Delivered by a certified diabetes education specialist with extensive clinical experience at Stanford Health Care, access accompanying presentation materials and connect with Stanford's Diabetes Care Program for ongoing support and resources. Additional mindfulness and meditation resources are available through Stanford Health Library to support overall wellness during treatment.
